title: [Insulin secretion and action in acromegaly].
abstract: 17 patients with active acromegaly (7 of them had diabetes mellitus, too), 13 patients with type I diabetes mellitus and 20 healthy controls were examined. The residual beta-cell secretion was determined by venous Tolbutamide test and the insulin sensitivity was determined by euglycemic clamp-technique. A positive correlation was found between the growth hormone level and prolactin and the size of the basic insulin secretion. In acromegaly (with or without diabetes) the sensitivity of beta-cell apparatus towards the stimulant Tolbutamide is preserved but the insulin reserves are diminished. There exists a positive correlation between the growth hormone level and the degree of insulin resistance and between the increased prolactin level and the degree of insulin resistance in acromegalic patients.
authors.forename: A M
authors.initials: AM
authors.lastname: Borisova
authors.forename: N
authors.initials: N
authors.lastname: Ovcharova
authors.forename: G
authors.initials: G
authors.lastname: Kirilov
mesh_terms: D000172:Acromegaly / Q000097:blood*; D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood; D005260:Female; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D008297:Male; D011388:Prolactin / Q000097:blood; D013997:Time Factors; D014044:Tolbutamide
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D011388:Prolactin; D013006:Growth Hormone; D014044:Tolbutamide
vernacular_title: Sekretsiia i deĭstvie na insulina pri akromegaliia.